LAUNCHING
CLINICAL TRIALS IN HOBART July 2021 saw the introduction of a clinical trials program at Icon Cancer Centre Hobart, the first private oncology clinical trials unit in Tasmania. In its infancy, the trials program at Hobart, delivered by an experienced clinical research coordinator and seven investigators, has forged important partnerships with key industry and collaborative group sponsors and has opened several trials across a broad portfolio including breast, skin, urothelial, prostate, lung, colorectal and upper GI clinical trials. Medical Oncologist, A/Prof Louise Nott has been instrumental in the establishment of the research portfolio, and it is thanks to this strong leadership that Hobart has been the site selected for 20 studies during 2021, five of which were activated within the year and the remainder due in the first quarter of 2022. This addition to the Tasmanian cancer care landscape will improve access to cancer care and further eliminate the need to travel interstate to access clinical trial opportunities.
A/PROF LOUISE NOTT BMedSci, MBBS(Hons), FRACP
Medical Oncologist A/Prof Nott is widely published and has acted as a Principal Investigator / Sub Investigator on over 50 oncology clinical trials across industry, collaborative and academic sectors. She holds an Honorary Associate position at Sydney Medical School and is a University Associate with the Menzies Research Institute in Tasmania.
30
ICON ANNUAL RESEARCH REPORT 2021
